Structural Overview
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide — a 15-amino acid sequence — derived from a portion of the human gastric protein BPC. Its molecular formula is C62H98N16O22 with a molecular weight of approximately 1419.5 Da. The compound is stable in aqueous environments across a range of pH conditions, a property that has made it a subject of interest in in-vitro stability studies.
As a research compound, BPC-157 is supplied in lyophilized form and requires reconstitution prior to use in laboratory assays. It is designated strictly for Research Use Only and is not approved for any diagnostic or therapeutic application.
Documented Receptor Interactions in Preclinical Models
Published preclinical literature has investigated BPC-157's interactions with several receptor systems in animal models and cell-based assays. Researchers have documented interactions with the nitric oxide (NO) system, with particular interest in its behavior relative to endothelial nitric oxide synthase (eNOS) activity in isolated cell preparations.
Additional in-vitro research has examined the compound's behavior in assays involving growth hormone receptor expression, vascular endothelial growth factor (VEGF) signaling, and FAK-paxillin pathway activity in fibroblast cultures. These findings are preliminary and based on controlled laboratory conditions — they do not constitute evidence of clinical efficacy in any indication.
Gastrointestinal Research Applications
A significant portion of BPC-157 research literature originates from gastroenterology-adjacent preclinical work. Studies have examined the compound's behavior in gastrointestinal mucosal cell cultures and rodent models of experimentally induced gastrointestinal lesions. Researchers have observed effects on prostaglandin synthesis pathways and mucosal cell proliferation markers in these controlled settings.
This body of work is exploratory and requires substantial further investigation before any mechanistic conclusions can be drawn about human biology.
Musculoskeletal Research Context
BPC-157 has been studied in rodent models evaluating tendon-to-bone interface healing and ligament cell behavior in culture. Investigators have reported observations related to fibroblast migration rates and collagen organization in in-vitro wound scratch assays. These findings have generated interest in BPC-157 as a research tool for studying connective tissue biology at the cellular level.
Analytical Considerations
When sourcing BPC-157 for research, purity verification is critical. Synthetic peptides of this length are susceptible to truncation products and racemization during synthesis. A robust analytical package — including HPLC purity quantification, mass spectrometry identity confirmation, and endotoxin testing — is essential for ensuring experimental validity. Red Hand Research provides lot-specific CoAs for every BPC-157 batch from ISO/IEC 17025:2017-accredited laboratories.
Current Research Landscape
BPC-157 remains an active area of preclinical investigation. As of the publication of this overview, no large-scale human clinical trials have been completed or published. All documented effects are from animal models or in-vitro systems. Researchers working with this compound should consult current primary literature for the most up-to-date findings and design their experiments accordingly.
This article is an overview of publicly available research literature and is provided for informational purposes for qualified researchers. It does not constitute medical advice, endorsement of any compound for human use, or a claim of efficacy for any indication. All compounds referenced are supplied for Research Use Only.